Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29156747 | 1.00 | TSHR (0.52) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL6418651 | 1.00 | TSHR (0.52) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL692882 | 1.00 | — | — | |
| SCHEMBL5909735 | 1.00 | TSHR (0.52) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL9559196 | 1.00 | — | — | |
| SCHEMBL29255850 | 1.00 | TSHR (0.52) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| SCHEMBL5909792 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL7560132 | 0.94 | TSHR (0.48) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| Hydrochloric Acid SCHEMBL7560137 | 0.94 | TSHR (0.48) | TSHRABCC4MAPTALDH1A1TRPA1 | |
| Hydrochloric Acid SCHEMBL6294447 | 0.91 | TSHR (0.43) | TSHRABCC4MAPTALDH1A1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024215620-A1 | SELECTIVELY DEPOSITING SILICON OXIDE ON A DIELECTRIC SURFACE OF A SUBSTRATE | LAM RESEARCH CORPORATION (US) | 2024-10-17 | — | — | WO | claimed |
| WO-2024205914-A1 | SELECTIVELY DEPOSITING A METAL OXIDE ON A DIELECTRIC SURFACE OF A SUBSTRATE | LAM RESEARCH CORPORATION (US) | 2024-10-03 | — | — | WO | claimed |
| US-12581877-B2 | Selective deposition of metal oxides using silanes as an inhibitor | LAM RESEARCH CORPORATION (US) | 2026-03-17 | — | — | US | disclosed |
| US-20260022454-A1 | METHODS OF SELECTIVE DEPOSITION AND CHEMICAL DELIVERY SYSTEMS | LAM RES CORP (US) | 2026-01-22 | — | — | US | disclosed |
| US-12401060-B2 | Nonaqueous secondary battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-08-26 | — | — | US | disclosed |
| EP-3780041-B1 | INTRAVASCULAR BLOOD PUMP WITH CORROSION RESISTANT PERMANENT MAGNET | ABIOMED EUROPE GMBH (DE) | 2025-07-30 | — | — | EP | disclosed |
| EP-4095872-B1 | CORROSION-RESISTANT PERMANENT MAGNET FOR AN INTRAVASCULAR BLOOD PUMP | ABIOMED EUROPE GMBH (DE) | 2025-07-30 | — | — | EP | disclosed |
| US-20250110399-A1 | PHOTOSENSITIVE COMPOSITION CONTAINING PFAS-FREE POLYCYCLOOLEFINIC TERPOLYMERS AND SEMICONDUCTOR DEVICE MADE THEREOF | PROMERUS, LLC (US) | 2025-04-03 | — | — | US | disclosed |
| US-20250110403-A1 | PHOTOSENSITIVE COMPOSITION CONTAINING PFAS-FREE POLYCYCLOOLEFINIC POLYMERS AND SEMICONDUCTOR DEVICE MADE THEREOF | PROMERUS, LLC (US) | 2025-04-03 | — | — | US | disclosed |
| WO-2025072211-A1 | PRETREATING SUBSTRATE FOR SELECTIVE DEPOSITION | LAM RESEARCH CORPORATION (US) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025006608-A1 | ENABLING SELECTIVE DEPOSITION OF TANTALUM NITRIDE BARRIER IN BEOL VIAS | LAM RESEARCH CORPORATION (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2016144677-A1 | PARTIALLY REACTED SILANE PRIMER COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2016-09-15 | — | — | WO | disclosed |
| US-20160257819-A1 | PARTIALLY REACTED SILANE PRIMER COMPOSITIONS | PRC-DESOTO INTERNATIONAL INCORPORATED | 2016-09-08 | — | — | US | disclosed |
| US-20160252813-A1 | Lithographic Printing Plate Precursors and Coating | VERICO TECHNOLOGY LLC | 2016-09-01 | — | — | US | disclosed |
| EP-2688917-A2 | HYDROSILYATION OF VINYL MACROMERS WITH METALLOCENES | Exxonmobil Chemical Patents Inc. (US) | 2014-01-29 | — | — | EP | disclosed |
| US-8501894-B2 | Hydrosilyation of vinyl macromers with metallocenes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-08-06 | — | — | US | disclosed |
| CN-101294216-B | Substrate structure, oligomer probe array and methods for producing the same | SAMSUNG ELECTRONICS CO LTD | 2013-03-20 | — | — | CN | disclosed |
| WO-2012134726-A2 | HYDROSILYATION OF VINYL MACROMERS WITH METALLOCENES | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-10-04 | — | — | WO | disclosed |
| US-20120245300-A1 | Hydrosilyation Of Vinyl Macromers With Metallocenes | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-09-27 | — | — | US | disclosed |
| CN-101294216-A | Substrate structure, oligomer probe array and methods for producing the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2008-10-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12581877-B2 | Selective deposition of metal oxides using silanes as an inhibitor | DSTYK, TFPI, ZFX | TSHR 844/4885ABCC4 3326/4885MAPT 3569/4885 |
| US-20120245300-A1 | Hydrosilyation Of Vinyl Macromers With Metallocenes | VIM, VCL, VIL1 | TSHR 4279/4885ABCC4 2599/4885MAPT 1750/4885 |
| US-20260022454-A1 | METHODS OF SELECTIVE DEPOSITION AND CHEMICAL DELIVERY SYSTEMS | HAO2, COXFA4L2, SLC39A3 | TSHR 522/4885ABCC4 1959/4885MAPT 1384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.